Addison disease is a relatively rare condition, which can have devastating consequences if not promptly recognized and appropriately treated. Often the insidious nature of the disease results in a delay in diagnosis in patients who are not recognized until an acute adrenal crisis develops. Improving inter-professional team members' awareness of this condition will improve outcomes for patients who have Addison disease. This activity describes the etiology, epidemiology, presentation, evaluation, and treatment of Addison's disease. It highlights the importance of the inter-professional team in recognizing and managing this condition.
Describe the etiology of Addison disease.
Review when Addison disease should be included in the differential diagnosis.
Outline the management options available for Addison disease.
Addison disease is an acquired primary adrenal insufficiency. A primary adrenal insufficiency is termed Addison disease when an autoimmune process causes the condition. It is a rare but potentially life-threatening emergency condition. It results from bilateral adrenal cortex destruction leading to decreased adrenocortical hormones, which may include cortisol, aldosterone, and androgens. Addison disease's insidious course of action usually presents with glucocorticoid deficiency followed by mineralocorticoid. However, it can also present acutely, often triggered by intercurrent illness. The presentation of adrenal insufficiency depends on the rate and extent of adrenal function involvement. The most common cause of primary adrenal insufficiency is autoimmune adrenalitis (Addison disease), associated with increased levels of 21-hydroxylase antibodies.
This is caused by an inability of the adrenal cortices to produce adequate adrenocortical hormones. Adrenal insufficiency is classified as primary or secondary.
Primary Adrenal Insufficiency
Any disease process which causes direct injury to the adrenal cortex can result in primary adrenal insufficiency (Addison disease).
Autoimmune: Autoimmune destruction of the adrenal glands is the most common cause of Addison disease. Autoimmune destruction can be an isolated finding or autoimmune polyglandular endocrinopathies (type 1 and 2). Patients with the autoimmune adrenal disease are more likely to have polyglandular autoimmune syndromes.
Type 1 autoimmune polyglandular syndrome is manifested by autoimmune polyendocrinopathy, candidiasis, and ectodermal dysplasia. The classic triad consists of hypoparathyroidism, Addison disease, and mucocutaneous candidiasis.
Type 2 autoimmune polyglandular syndrome comprises several associations.
Autoimmune thyroiditis (Schmidt syndrome).
Type 1 diabetes (Carpenter syndrome).
Autoimmune conditions such as pernicious anemia, vitiligo, or alopecia.
Addison disease has been reported with celiac disease.
Infections: This includes sepsis, tuberculosis, cytomegalovirus, and HIV. The prevalence of tuberculosis has declined, but HIV has emerged as the most important cause of adrenal insufficiency associated with adrenal necrosis. Other infectious causes include disseminated fungal infections, histoplasmosis, and syphilis. Blastomycosis is a common cause in South America.
Adrenal Hemorrhage: Bilateral adrenal hemorrhages can be precipitated by DIC, trauma, meningococcemia, neoplastic processes. An Adrenal crisis due to meningococcemia is known as the Waterhouse-Friderichsen syndrome. This is more common in children and patients with asplenia.
Infiltration: Adrenal infiltration occurs in hemochromatosis, amyloidosis, and metastases.
Other causes include sarcoidosis, lymphoma, and genetic disorders such as congenital adrenal hyperplasia and adrenal leukodystrophy. Wolman disease is a rare inborn error of metabolism that presents with diarrhea, hepatosplenomegaly, failure to thrive, and calcification of adrenal glands. Anti-phospholipid antibody syndrome has been identified as a cause of adrenal insufficiency.
Drugs: Certain drugs can cause adrenal insufficiency by blocking cortisol synthesis.
Etomidate selectively inhibits 11β-hydroxylase, which converts deoxycortisol to cortisol. The effect of etomidate is dose-dependent. 
Secondary Adrenal Insufficiency
Secondary insufficiency occurs most commonly due to exogenous steroid administration resulting in the suppression of ACTH synthesis. It is a pituitary-dependent loss of ACTH secretion, which results in a reduction of glucocorticoid production. However, mineralocorticoid secretion, including aldosterone, remains at a relatively normal level. It is more common than primary insufficiency. Symptoms usually occur after discontinuation of the steroid.
Addison disease is rare. The incidence is 0.6 per 100,000 of the population per year. The total number of people affected by this condition at a given time ranges from 4 to 11 per 100,000 of the population. In adults, the common age of presentation is 30 to 50 years. It is more common in women.
Risk factors for the autoimmune (most common) type of Addison's disease include other autoimmune diseases:
Type I diabetes
Adrenal failure in Addison disease results in decreased cortisol production initially followed by that of aldosterone, both of which will eventually result in an elevation of adrenocorticotropic (ACTH) and melanocyte-stimulating hormone (MSH) hormones due to the loss of negative feedback inhibition.
History and Physical
Addison disease usually manifests as an insidious and gradual onset of non-specific symptoms, often resulting in a delayed diagnosis. The symptoms may worsen over a period of time, which makes early recognition difficult. A high clinical suspicion should be maintained to avoid misdiagnosis. In many cases, the diagnosis is made only after the patient presents with an acute adrenal crisis (hypotension, hyponatremia, hyperkalemia, and hypoglycemia). This may be precipitated by a stressful illness or such triggering factors such as infection, trauma, surgery, vomiting, or diarrhea. Significant stress or illness can unmask cortisol and mineralocorticoid deficiency.
Addison disease can occur at any age but most often presents during the second or third decades of life. The initial presentation includes fatigue, generalized weakness, weight loss, nausea, vomiting, abdominal pain, dizziness, tachycardia, and/or postural hypotension. Hyperpigmentation is characteristic and occurs in almost all patients. It is usually generalized and most prominent in sun-exposed and pressure areas. Elevated ACTH and melanocyte-stimulating hormone are causative factors. It is believed that ACTH binds to the melanocyte receptors, which are responsible for pigmentation. Hyperpigmentation is more pronounced over palmar creases, gingival mucosa, lips (particularly vermilion border), elbows, knuckles, posterior neck, breast areola, nipples, and nail beds. Hyperpigmentation is not seen in secondary insufficiency because ACTH and MSH levels are low. Multiple new nevi may develop. Decreased or sparse axillary and pubic hair may occur in female patients.
Due to its variable presentation, a high index of suspicion for Addison disease is necessary when evaluating a conglomeration of non-specific symptoms. These may include unexplained fatigue, poor appetite, chronic abdominal pain, or weight loss. Hyponatremia with or without hyperkalemia and/or hypotension can often be seen in Addison disease. Addisonian crisis is often manifested by severe dehydration, confusion, refractory hypotension, and shock. It is more likely to occur in primary adrenal insufficiency than secondary adrenal insufficiency.
The diagnosis is established by demonstrating low cortisol and aldosterone levels, high renin level, and a blunt cortisol response with ACTH stimulation. The approach for the evaluation s as follows;
Assessing the adrenal cortex's functional capacity to synthesize cortisol and determine whether the cortisol deficiency is related to a corticotropin (ACTH) deficiency. This will help to classify whether the adrenal insufficiency as primary or secondary.
Determining whether a treatable cause is present. Further evaluation should be directed to determine its underlying cause.
Typically, a low random cortisol level is seen. Cortisol follows a diurnal pattern; it is highest in the early morning; therefore, an early morning level should be obtained. However, it is not practical to obtain an early morning cortisol level in the emergency department (ED). Also, these results are not readily available at the time of ED presentation. A single determination of serum cortisol level is not sufficient to assess adrenal function. However, a morning cortisol level over 18 micrograms/dL is considered normal and may exclude the diagnosis. A low cortisol level (< 3 mcg/dL) is sufficient to diagnose adrenal insufficiency.
>18 microgram/dL = Normal
<3 microgram/dL = Adrenal insufficiency
3-19 microgram/dL /dL = Equivocal and further evaluation is suggested.
ACTH Level and Corticotropin Stimulation Test
The ACTH level is markedly elevated in primary adrenal insufficiency. However, the level is not elevated or within the reference range in patients with central adrenal insufficiency. In equivocal cases, the diagnosis is confirmed by an ACTH (cosyntropin) stimulation test. It causes rapid stimulation of cortisol and aldosterone secretion. This is a first-line diagnostic test for the evaluation of adrenal insufficiency. Plasma cortisol levels should be measured at 0 and 30 to 60 minutes after administration of ACTH. CRH stimulates ACTH release from the pituitary. In primary adrenal insufficiency, a high ACTH level is present, which rises further after CRH stimulation but unable to stimulate serum cortisol secretion. However, in secondary adrenal insufficiency, a low ACTH level is seen, failing to respond to CRH.
Primary adrenal insufficiency: elevated ACTH
Central adrenal insufficiency: abnormally normal or low ACTH
With ACTH stimulation
Normal response = Adequate response (peak cortisol level >18 mcg/dL)
Serum renin and aldosterone levels should be obtained to determine whether a mineralocorticoid deficiency is present. Both cortisol and aldosterone are missing in primary adrenal insufficiency. A low aldosterone concentration is present despite markedly increased plasma renin activity. In secondary adrenal insufficiency, the aldosterone level will be normal. Increased plasma renin activity can be seen; this indicates that there is adrenal cortex dysfunction. A high level occurs when there is a low level of serum aldosterone.
Typical laboratory findings include hyponatremia, hyperkalemia, and hypoglycemia. Hyponatremia is due to cortisol and aldosterone deficiency. Aldosterone deficiency causes sodium wasting, and cortisol deficiency results in the increased antidiuretic hormone. This causes increased water absorption. Hypovolemia also triggers ADH secretion. Hyperkalemia is secondary to low aldosterone levels, which causes natriuresis and potassium retention. Hyperkalemiadoes not occurin secondary disease; this helps to distinguish from primary adrenal insufficiency. Hypoglycemia is multifactorial, including decreased oral intake and lack of glucocorticoids, which are essential for gluconeogenesis. Hypoglycemia is multifactorial, including decreased oral intake and lack of glucocorticoids, which are essential for gluconeogenesis. Hypercalcemia may be present, which reflects extracellular fluid loss.
Slight elevation of TSH level can occur in adrenal insufficiency. This occurs due to a decrease in cortisol level and abnormal TSH circadian rhythm. If TSH elevation persists, a possibility of hypothyroidism should be considered.
Anti-adrenal antibodies (such as 21-hydroxylase antibodies) serve as the markers of autoimmune destruction of the adrenal gland. The 21-hydroxylase enzyme is essential for cortisol synthesis in the adrenal cortex. This may be helpful to determine the cause of Addison disease. It is also important to evaluate other organ-specific autoimmune conditions.
A chest radiograph may reveal a small heart; this may be due to a decrease in the cardiac workload. In suspected cases of adrenal hemorrhage, an abdominal CT scan may provide useful information in determining the cause. For example, bilateral enlargement of the adrenal glands may be seen with adrenal hemorrhage.
Autoimmune adrenal destruction-- i.e., small adrenals.
Tuberculosis-- i.e., calcification or hemorrhage.
A magnetic resonance imaging (MRI) of the hypothalamic-pituitary region should be obtained if ACTH is inappropriately low in the presence of cortisol deficiency. A pituitary baseline profile should also be obtained. The radiographic findings are non-specific. A biochemical diagnosis of adrenal insufficiency should be made before obtaining radiographic studies.
Additional studies should be directed to determine the underlying cause. A PPD test should be performed to evaluate for tuberculosis. Plasma very-long-chain fatty acid profile should be obtained in cases where adrenal leukodystrophy is suspected. Complete blood count (CBC) may reveal neutropenia, lymphocytosis, and eosinophilia. ECG may show tall and peaked T waves if hyperkalemia is present. Histology is useful to investigate infiltrative causes of adrenal insufficiency. The finding of caseating granulomas may suggest tuberculosis, whereas a non-caseating granuloma may be due to sarcoidosis.
Treatment / Management
Early recognition is critical for the management of adrenal insufficiency. Addison crisis is a severe endocrine emergency; immediate recognition and treatment are required. Beware that if not recognized and treated, the adrenal crisis can be fatal. The confirmatory laboratory evaluation should not delay the treatment. Blood samples should be obtained for subsequent measurement of ACTH and cortisol levels. The elevation of ACTH with low cortisol is diagnostic of a primary adrenal insufficiency. Measurement of cortisol in the ACTH stimulation test may be performed when initial laboratory evaluation cannot establish the diagnosis. Plasma renin level is often elevated and is indicative of a mineralocorticoid deficiency, accompanied by a low aldosterone level.
Patients with an adrenal crisis require the following:
Fluid resuscitation to restore the intravascular volume with intravenous (IV) normal saline
Dextrose to correct hypoglycemia
Correction of the hormone deficiency, both glucocorticoid and mineralocorticoid
The immediate hormonal treatment is the administration of hydrocortisone. The initial dose for adrenal crisis is 100 mg IV bolus, followed by 50 to 100 mg IV every 6 hours over 24 hours. In children, the dose is 50 mg/m^2 (max: 100 mg) IV bolus, followed by 50 to 100 mg/m^2. Since this dose has significant mineralocorticoid activity, mineralocorticoids such as fludrocortisone are unnecessary during the acute phase. Dexamethasone 4-mg IV bolus can be considered in the ED when emergent steroids administration is required; it is less likely to interfere with the serum cortisol assays. It is long-acting and does not interfere with biochemical assays of endogenous glucocorticoid production. Prednisone and dexamethasone have little or no mineralocorticoid activity. The initial fluid replacement is normal saline bolus followed by 5% glucose in isotonic saline. Hypoglycemia should be treated promptly.
Life-long treatment with hormonal replacement is required. Maintenance therapy aims to provide a replacement to maintain a physiologic glucocorticoid and mineralocorticoid level. The usual doses are as follows;
Glucocorticoid: Hydrocortisone 5 to 25 mg/day (can be divided into 2 or 3 doses)
Prednisone 3 to 5 mg/day
Doses should be adjusted according to the clinical response and normalization of electrolyte abnormalities. To minimize adverse effects, the dose should be titrated to the lowest possible dose that controls symptoms; ensure the patient is clinically well. Plasma Renin level can also be used to adjust the doses. Serum ACTH levels may vary significantly and cannot be used for dose adjustment. It is important to consider concurrent medications when deciding the glucocorticoid dose. For example, certain drugs such as Rifampin can increase hepatic glucocorticoid metabolism and may inactivate cortisol. Dexamethasone is not an appropriate choice for maintenance treatment; the dose titration is difficult and increases the risk of the Cushing effect.
Mineralocorticoid: Fludrocortisone 0.05 to 0.2 mg daily.
In children, the initial hydrocortisone dose is 8 mg/m^2/day orally; this can be divided into 3 or 4 doses.
Fludrocortisone should be administered at a sufficient dose to keep the plasma renin level in the reference range. An elevated PRA indicates a higher dose of fludrocortisone is required. The mineralocorticoid dosage should be tailored to address the degree of stress. Furthermore, the identification and treatment of underlying causes such as sepsis are critical for an optimal outcome. The treatment of associated conditions should also be provided.
In patients with Addison’s disease, glucocorticoid secretion does not increase during stress. Therefore, in the presence of fever, infection, or other illnesses, the hydrocortisone dose should be increased to compensate for a possible stress response.
In general, ausual stress dose is 2-3 times the daily maintenance dose.
Patients taking rifampin require an increased dose of hydrocortisone, as it increases the clearance of hydrocortisone.
Thyroid hormone can increase the hepatic clearance of cortisol; this can precipitate an adrenal crisis. Glucocorticoid replacement can potentially normalize thyroid-stimulating hormone.
In patients with concomitant diabetes insipidus, glucocorticoid therapy can aggravate diabetes insipidus. Cortisol is required for free-water clearance, and cortisol deficiency may prevent polyuria.
Pregnancy, particularly during the third trimester, increases corticosteroid requirements.
The differential diagnosis of adrenal crisis includes most other conditions that can cause shock. The differential diagnosis of adrenal insufficiency is broad. Some common differential diagnoses are discussed here.
Many features of sepsis overlap with adrenal insufficiency. The presentation includes weakness, fatigue, vomiting, hypotension, and shock. The confirmation of primary adrenal insufficiency diagnosis is made by low cortisol response to ACTH stimulation test and low ACTH level.
Shock (due to any cause)
Plasma cortisol level with shock suggests adrenal insufficiency.
Chronic Fatigue Syndrome
Chronic persisting or relapsing fatigue may mimic adrenal insufficiency. However, laboratory evaluations such as cortisol level after corticotropin stimulation differentiate it from adrenal insufficiency.
The presentation may be similar to fever, fatigue, and myalgias may occur in both conditions. However, exudative pharyngitis is present in this condition. IgM antibodies to viral capsid antigen are present.
As with adrenal insufficiency, fatigue may be present in hypothyroidism. However, it is associated with weight gain. The cortisol level should differentiate both conditions.
Toxicity and Side Effect Management
A delay in initiating the treatment can have serious consequences and may increase rates of morbidity and mortality.
The treatment of Addison disease is a life-long replacement of glucocorticoids and mineralocorticoids. A strict balance is required to avoid over-or under-treatment with glucocorticoids. Therefore, careful monitoring is required. Over-treatment with glucocorticoids may result in obesity, diabetes, and osteoporosis. Over-treatment with mineralocorticoids can cause hypertension. Patients with Addison disease are at increased risk of developing other autoimmune conditions; up to 50% of patients with Addison disease may develop another autoimmune condition. Thyroid hormone replacement may precipitate an adrenal crisis in unrecognized patients.
Addison disease can develop into an adrenal crisis if not recognized and promptly treated. This can result in hypotension, shock, hypoglycemia, acute cardiovascular decompensation, and death. Patients with adrenal insufficiency are also at higher risk of death due to infections, cancer, and cardiovascular causes. Delayed recognition and treatment of hypoglycemia can cause neurologic consequences. A supraphysiologic glucocorticoid replacement can lead to the development of Cushing syndrome. Growth suppression can occur in children. Premature ovarian failure or primary ovarian insufficiency may develop in up to 10% of women with Addison disease.
The treatment plan should be developed in consultation with an endocrinologist. All patients with an adrenal crisis should be consulted with intensivists and admitted to an intensive care unit (ICU). Patients who are ill-appearing and present with shock should be admitted to ICU.
Deterrence and Patient Education
Patients with Addison disease should receive education about management and monitoring.
Medication doses and compliance with the treatment plan; provide education about the need to increase steroid replacement doses in stressful situations such as fever, surgery, or stress.
Having an emergency medical alert bracelet.
Self-care, including adequate sodium intake in the diet, weight, and blood pressure monitoring.
Pearls and Other Issues
Idiopathic autoimmune adrenocortical insufficiency is the most common cause of Addison disease.
Symptoms of Addison disease can be non-specific and, therefore, can be difficult to recognize. A high index of suspicion is required to make this diagnosis.
Plasma cortisol < 3 mcg/dL at 8 with a simultaneous elevation of the plasma ACTH level >200 pg/mL establishes the diagnosis.
Primary adrenal insufficiency diagnosis should be considered in acutely ill patients presenting volume depletion, hypotension, hyponatremia, and hyperkalemia.
It is important to consider the possibility of adrenal insufficiency in critically ill patients who failed to improve with resuscitation with fluid administration, particularly in the presence of hyperpigmentation, hyponatremia, or hyperkalemia.
In an Addisonian crisis, treatment is a priority and should not be delayed for diagnostic confirmation; a delayed treatment can be fatal.
The treatment of choice for adrenal crisis is hydrocortisone; this has both glucocorticoid and mineralocorticoid properties.
Glucocorticoid doses should be increased in the presence of fever, infection, or other stresses.
Titrate the glucocorticoid dose to the lowest possible dose, which can control symptoms and minimize the adverse effects.
Thyroid hormone treatment can precipitate an adrenal crisis since the thyroid hormone can increase the hepatic clearance of cortisol.
Serum cortisol, plasma ACTH, plasma aldosterone, and plasma renin levels should all be obtained before performing the ACTH stimulation test.
Addison disease due to autoimmune adrenalitis can develop another autoimmune disorder.
Enhancing Healthcare Team Outcomes
Addison disease is a life-threatening condition that requires accurate diagnosis and prompt treatment. If the diagnosis is delayed, it carries high morbidity and mortality. Thus, the condition is best managed by an interprofessional team of healthcare workers that include an endocrinologist, an intensivist, an infectious disease specialist, and a pharmacist. The education of the patient is critical for patients with chronic conditions. Physicians, nurses, and pharmacists can share this responsibility. Nurses need to administer treatments, monitor patients, and provide updates to the team. Once the diagnosis is established, the outcomes depend on the primary cause. Any delay in initiating the treatment can lead to poor outcomes. All patients who have Addison disease must be urged to wear a medical alert bracelet. Patients should be educated regarding the signs and symptoms. They should be urged to contact their primary care provider if there are any warning symptoms. Finally, in times of stress, such as fever, patients should be instructed to double the dose of steroids and see their primary care provider. [Level 5]
Yamamoto T, Latent Adrenal Insufficiency: Concept, Clues to Detection, and Diagnosis. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2018 Aug [PubMed PMID: 30084678]
Westra SJ,Zaninovic AC,Hall TR,Kangarloo H,Boechat MI, Imaging of the adrenal gland in children. Radiographics : a review publication of the Radiological Society of North America, Inc. 1994 Nov [PubMed PMID: 7855344]
Burton C,Cottrell E,Edwards J, Addison's disease: identification and management in primary care. The British journal of general practice : the journal of the Royal College of General Practitioners. 2015 Sep [PubMed PMID: 26324491]
Erichsen MM,Løvås K,Skinningsrud B,Wolff AB,Undlien DE,Svartberg J,Fougner KJ,Berg TJ,Bollerslev J,Mella B,Carlson JA,Erlich H,Husebye ES, Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. The Journal of clinical endocrinology and metabolism. 2009 Dec [PubMed PMID: 19858318]
Dickstein G,Shechner C,Nicholson WE,Rosner I,Shen-Orr Z,Adawi F,Lahav M, Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. The Journal of clinical endocrinology and metabolism. 1991 Apr [PubMed PMID: 2005201]
Samuels MH, Effects of variations in physiological cortisol levels on thyrotropin secretion in subjects with adrenal insufficiency: a clinical research center study. The Journal of clinical endocrinology and metabolism. 2000 Apr [PubMed PMID: 10770171]
Oelkers W,Diederich S,Bähr V, Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone. The Journal of clinical endocrinology and metabolism. 1992 Jul [PubMed PMID: 1320051]
Bornstein SR,Allolio B,Arlt W,Barthel A,Don-Wauchope A,Hammer GD,Husebye ES,Merke DP,Murad MH,Stratakis CA,Torpy DJ, Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism. 2016 Feb [PubMed PMID: 26760044]
Chantzichristos D,Eliasson B,Johannsson G, MANAGEMENT OF ENDOCRINE DISEASE Disease burden and treatment challenges in patients with both Addison's disease and type 1 diabetes mellitus. European journal of endocrinology. 2020 Jul; [PubMed PMID: 32299062]